Cell MedX Corp. (CMXC)

USD 0.43

(0.0%)

Market Cap (In USD)

126.32 Million

Revenue (In USD)

-

Net Income (In USD)

-142.48 Thousand

Avg. Volume

16.03 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.0E-4-3.419999
PE
-
EPS
-
Beta Value
32.646
ISIN
US15115X1072
CUSIP
15115X107
CIK
1493712
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. David M. Jeffs
Employee Count
-
Website
https://www.cellmedx.com
Ipo Date
2013-08-29
Details
Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada.